The Latest Breaking News from FDA

Popular over-the-counter gas medication sold in US recalled for possible contamination

The medication was sold at retailers nationwide

The Independent UK · Jun 6

Trump tariffs changed taste of foods in U.S? Label checking reveals shocking details

Trump Tariffs have grabbed headlines and become the topic of discussion around the world. Now there is a reality-check on the food ingredients.

The Economic Times · Jun 6

Ozempic Is Now Fighting America's Addiction Crisis — A Massive VA Study Covering 600,000 Veterans Is Rewriting What We Know About Substance Abuse

Drugs like Ozempic and Wegovy — already reshaping obesity treatment — may also slash overdose deaths, ER visits, and alcohol dependence, according to the largest study ever conducted on GLP-1s and addiction.

Medical Daily · Jun 6

RFK Jr’s FDA to study if abortion pill mifepristone is safe despite it being on market for over 25 years: report

Roughly 7.5 million women have taken the pill over the past 25 years

The Independent UK · Jun 5

With Nation's Highest Diabetes Rate, San Antonio Faces Major Shift as Medicare Prepares $50 Wegovy Coverage

With diabetes rates among the highest in the U.S., San Antonio could see major change as Medicare's new $50 Wegovy coverage begins July 1, expanding access for eligible residents.

Medical Daily · Jun 5

Almost 15,000 illegal health products seized in Bangkok warehouse raid

A warehouse raid in Bangkok’s Lat Krabang district seeking illegal dietary supplements, cosmetics and herbal products seized nearly 15,000 items worth more than 2 million baht on Friday.

Bangkok Post · Jun 5

Alvotech Nears Inflection Point With 5 U.S. Biosimilars Targeted by Year-End

Alvotech (NASDAQ:ALVO) is at an “inflection point” after more than a decade of investment in its biosimilar platform, Founder and Executive Chairman Róbert Wessman said at the Jefferies Global Healthcare Conference in New York. Speaking with Jefferies analyst Marco Baruzzi, Wessman said Alvotech ha

MarketBeat · Jun 5

Aldeyra Therapeutics Eyes FDA Feedback as Dry Eye Drug Faces Make-or-Break Moment

Aldeyra Therapeutics (NASDAQ:ALDX) Chief Executive Todd Brady said the company expects near-term feedback from the U.S. Food and Drug Administration on its dry eye disease candidate reproxalap, following a third complete response letter tied to efficacy questions. Speaking at a Jefferies fireside c

MarketBeat · Jun 5

Optellum Celebrates Accelerating Impact in Lung Cancer Care; Now at Over 250 Sites and Growing

OXFORD, United Kingdom and HOUSTON, June 5, 2026 /PRNewswire/ -- Optellum, a leader in AI-enabled lung cancer diagnostics, today announced that it has surpassed 250 clinical sites and analyzed more than 3 million cases to date. This milestone underscores Optellum's commitment to empowering health systems and clinical care teams with…

AAP · Jun 4

"Transformative Advance" in Cancer Treatment Emerges in Dallas — New Pill Shows Rare Survival Jump in Pancreatic Cancer Patients

Pancreatic Cancer treatment may be entering a new era as a breakthrough pill nearly doubles survival in metastatic patients, offering new hope for one of the deadliest forms of cancer.

Medical Daily · Jun 4